Leveraging Technology to Cut Through the REMS Confusion

The Risk Evaluation and Mitigation Strategies (REMS) program has taken center stage recently as the Food and Drug Administration (FDA), pharmacies and healthcare providers seek ways to improve and streamline its administration. Created in 2007 as part of the FDA Amendments Act, REMS was designed to ensure that the benefits of a drug or biological product outweigh its risks, as well as for post-marketing surveillance of medication safety. While providers agree with these goals, many are also concerned with issues they believe are preventing REMS from achieving its objectives.

Download White Paper

You may also like:

Blog Post

The problem of alert fatigue — the negative or overwhelmed reaction of clinicians to receiving too many intrusive or irrelevant notifications from electronic health record (EHR) systems — continues to vex clinicians, s...

View Blog Post
Blog Post

Open source software — like the famed operating system Linux — makes its source programming code openly available to download. Users also contribute to the development of the software by sharing how they have employe...

View Blog Post
Blog Post

Over the last several decades, clinical decision support solutions have demonstrated success in helping improve quality of care in the American healthcare system. But the need to “broaden that impact” has led professionals to ...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up